| Number of (%) of patients N = 3815 | ||
Intervention n = 1351 | Control n = 2464 | p-value | |
Sex, females (%) | 643 (47.59) | 1266 (51.38) | 0.025 |
Age, mean years (SD) | 67.24 (±13.31) | 64.60 (± 14.65) | < .001 |
HbA1c, mean % (SD) | 7.25 (±1.88) | 6.68 (± 1.12) | 0.088* |
Blood pressure, mean mm Hg (SD) | |||
 Systolic | 133.39 (±15.01) | 132.93 (± 14.21) | 0.34* |
 Diastolic | 77.69 (±7.97) | 78.26 (± 19.18) | 0.77* |
LDL cholesterol, mean mg/dL (SD) | 92.16 (±34.12) | 97.85 (± 34.68) | 0.19* |
Number of patients on target for clinical variables | |||
 HbA1c, number of (%) | 356/599 (59.43%) | 777/1104 (70.38%) | 0.03** |
 Blood pressure, number of (%) | 797/1018 (78.29%) | 1180/1507 (78.30%) | 0.99** |
 LDL cholesterol, number of (%) | 432/672 (64.29%) | 850/1475 (57.63%) | 0.11** |
Number of patients on target for process variables | |||
 Quarterly check HbA1c | 28/1351 ( 2.07%) | 107/2464 (4.34%) | 0.42** |
 Quarterly check blood pressure | 263/1351 (19.47%) | 392/2464 (15.91%) | 0.59** |
 Yearly check LDL cholesterol | 780/1351 (57.74%) | 1489/2464 (60.43%) | 0.75** |
 Yearly check micro-albuminuria | 11/1351 (0.81%) | 202/2464 (8.20%) | 0.03** |
 Prescription of statin | 425/1351 (31.46%) | 677/2464 (27.48%) | 0.24** |
 Prescription of aspirin/clopidogrel | 44/1351 (3.26%) | 57/2464 (2.31%) | 0.12** |
 Prescription of ACE-Inhibitors/sartans if antihypertensive drugs are prescribed | 716/1092 (65.57%) | 1084/1658 (65.38%) | 0.97** |
 | Number of (%) of physicians N = 52 | ||
Intervention n = 21 | Control n = 31 | p-value | |
Sex, females (%) | 10/21 (47.62) | 10/31 (32.26) | 0.38 |
Age, mean years (SD) | 51.19 (± 11.70) | 50.94 (± 15.93) | 0.83 |
Language, Dutch (%) | 14/21 (66.67) | 18/31 (58.06) | 0.58 |